Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Report Overview
The renal biomarkers market was valued at USD 1044.64 Million in 2025. It is poised to grow at a CAGR of 7.65% during the forecast period of 2026-2035, and reach USD 2183.27 Million by 2035. The market growth is driven by the rising prevalence of kidney diseases, increasing demand for early diagnosis, advancements in biomarker technologies, and expanding adoption of precision diagnostics globally.
Latest News on Renal Biomarkers Market (2026)
- In February 2026, Abbott Laboratories received FDA approval for its next-generation CardioMEMS monitoring system, improving disease progression tracking.
- In November 2025, Abbott Laboratories announced a USD 23 billion acquisition of Exact Sciences, expanding diagnostics capabilities and strengthening biomarker innovation to support renal testing adoption globally.
- In March 2025, BioPorto Diagnostics A/S expanded U.S. adoption of its NGAL-based kidney injury test following regulatory progress, improving early diagnosis and supporting renal biomarker market growth.
Key Market Trends and Insights
- Based on biomarker type, the functional biomarker segment dominated the market and accounted for the largest revenue share of about 51% in the historical period.
- Based on technique, the enzyme-linked immunosorbent assay segment held the largest revenue share of above 43% in the historical period.
- Based on the region, North America is expected to dominate the market, accounting for the largest revenue share of over 48% in the historical period.
Market Size and Forecast
- Market Size (2025): USD 1044.64 Million
- Projected Market Size (2035): USD 2183.27 Million
- CAGR (2026-2035): 7.65%
Compound Annual Growth Rate
7.65%
Value in USD Million
2026-2035
Read more about this report - Request a Free Sample
Renal Biomarkers Market Overview
The market is experiencing steady growth due to rising prevalence of kidney disorders and increasing demand for early diagnostic tools. Advancements in biomarker discovery and clinical testing are improving disease detection and monitoring. Growing adoption of glomerular filtration rate (GFR) assessment is enhancing diagnostic accuracy, supporting effective management of kidney function and driving market expansion globally. The market reached a value of approximately USD 1044.64 Million in 2025.
Renal Biomarkers Market Growth Drivers
Diagnostic Advancements Supporting the Market Innovation
The rising prevalence of kidney disorders and increasing demand for early detection are driving market expansion. For instance, in March 2025, BioPorto Diagnostics A/S expanded U.S. adoption of its NGAL-based kidney injury test following regulatory progress. This development is strengthening utilization of NGAL, improving early diagnosis, and supporting market growth during the forecast period. Additionally, increasing awareness regarding chronic kidney disease management and the growing adoption of biomarker-based diagnostic approaches are further accelerating demand for advanced renal testing solutions globally.
Renal Biomarkers Market Trends
Key trends shaping the market include increasing adoption of early diagnostic biomarkers, advancements in assay technologies, and rising focus on kidney disease management globally.
Strategic Investments Advancing Renal Biomarkers Market Value
The rising prevalence of kidney disorders and increasing investment in diagnostic technologies are supporting market expansion. For instance, in November 2025, Abbott Laboratories announced a USD 23 billion acquisition of Exact Sciences to expand its diagnostics portfolio. This development is strengthening biomarker innovation and enhancing the adoption of creatinine, supporting long-term market growth.
Renal Biomarkers Market Segmentation
Market Breakup by Biomarker Type
- Functional Biomarker
- Up-Regulated Proteins
- Others
Market Breakup by Technique
- Enzyme Linked Immunosorbent Assay
- Particle Enhanced Turbidimetric Immunoassay
- Calorimetric Assay
- Chemiluminescent Enzyme Immunoassay
- Liquid Chromatography Mass Spectrometry
Market Breakup by Application
- Diagnosis and Disease progression Monitoring
- Research Homecare
- Others
Market Breakup by End Users
- Diagnostic labs
- Outpatient Clinics
- Research Centers
- Hospitals
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Renal Biomarkers Market Share
Enzyme-Linked Immunosorbent Assay Likely to Lead the Market Segment by Technique
The enzyme-linked immunosorbent assay segment led the market, accounting for over 43% of revenue in the historical period. Its dominance is supported by high sensitivity, cost-effectiveness, and widespread clinical adoption. Increasing utilization of assays for detecting cystatin C is enhancing diagnostic accuracy, supporting early disease detection and strengthening segment growth across laboratory and hospital settings globally.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Read more about this report - Request a Free Sample
Renal Biomarkers Market Analysis by Region
North America is anticipated to dominate the global market, accounting for over 48% of revenue in the historical period. The region benefits from advanced healthcare infrastructure, strong diagnostic adoption, and high disease awareness. Growing use of glomerular filtration rate (GFR) assessment is improving kidney function evaluation, supporting early diagnosis and reinforcing regional leadership in biomarker-based clinical testing.
Leading Players in the Renal Biomarkers Market
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Abbott Laboratories
Headquartered in Abbott Park, Illinois, USA, and founded in 1888, Abbott Laboratories offers a broad diagnostics portfolio, including renal testing assays. Its solutions support early detection and monitoring of kidney diseases using biomarkers such as cystatin C and creatinine. The company emphasizes glomerular filtration rate(GFR) assessment to enhance diagnostic accuracy in chronic kidney disease management globally.
BioPorto Diagnostics AS
Based in Copenhagen, Denmark, and established in 2000, BioPorto Diagnostics specializes in kidney injury diagnostics. Its flagship NGAL-based assays support early detection of acute kidney injury. For instance, in June 2025, the company initiated US commercialization of its ProNephro AKI test, strengthening the adoption of NGAL as a leading acute kidney injury biomarker.
F.Hoffmann-La Roche AG
Headquartered in Basel, Switzerland, and founded in 1896, Roche is a global leader in diagnostics and pharmaceuticals. Its renal portfolio includes advanced biomarker assays integrated into automated platforms. The company collaborates on NGAL-based diagnostics to enhance early kidney injury detection, supporting clinical adoption of acute kidney injury biomarker technologies across hospital and laboratory settings globally.
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc., headquartered in Waltham, Massachusetts, USA, and founded in 2006, provides analytical instruments and diagnostic solutions. Its biomarker portfolio includes assays for kidney function monitoring and research applications. The company supports biomarker discovery and clinical testing using advanced platforms, enabling evaluation of creatinine levels and other indicators for kidney disease diagnosis and monitoring progression globally.
Other key players in the market are BioMerieux SA, Sphingotec GmbH, Enzo Life Sciences Inc., Siemens Healthineers AG, Randox Laboratories Ltd., and Q² Solutions Company.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Key Questions Answered in the Renal Biomarkers Market Report
- What was the renal biomarkers market value in 2025?
- What is the renal biomarkers market forecast outlook for 2026-2035?
- What major factors aid the demand for the renal biomarkers market?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market’s major drivers, opportunities, and restraints?
- What are the major renal biomarkers market trends?
- Which biomarker type is expected to dominate the market segment?
- Which technique is expected to dominate the market segment?
- Which application is expected to dominate the market segment?
- Which end user is expected to dominate the market segment?
- Who are the key players in the renal biomarkers market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Pricing Plans
Upto 15% Off
USD
-
$3299 $2969
-
$5499 $4949
-
$6999 $5949
-
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Report Summary
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Biomarker Type |
|
| Breakup by Technique |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
